학술논문
One year safety and immunogenicity of AZD1222 (ChAdOx1 nCoV-19): Final analysis of a randomized, placebo-controlled phase 1/2 trial in Japan
Document Type
Short Communication
Author
Source
In Vaccine 29 June 2023 41(29):4199-4205
Subject
Language
ISSN
0264-410X